Nano zinc oxide against bacteria isolated from burn infection

Authors

Mohammed Jaafar AL-Anssari, College of Medicine, University of Alkafeel, Al-Najaf, Iraq.Follow
Mohammed Sahib AL-Hamami, College of Medicine, University of Alkafeel, Al-Najaf, Iraq
Hayder Razzaq AL-Ameedee, College of Medicine, University of Alkafeel, Al-Najaf, Iraq
Rabab Abdul Razzaq Kasema, College of Health and Medical Techniques, University of Alkafeel, Al-Najaf, Iraq
Hawraa Majid Mahdi, College of Health and Medical Techniques, University of Alkafeel, Al-Najaf, Iraq.

Abstract

Pseudomonas aeruginosa is a type of bacteria that is found commonly in the environment, like in soil and in water. This bacteria can cause infections in the blood, lungs (pneumonia), or other parts of the body after surgery. These bacteria are constantly finding new ways to avoid the effects of the antibiotics used to treat the infections they cause. Zinc oxide nanoparticles' (ZnO-NPs') or Nano zinc oxide antibacterial properties have drawn a lot of attention from around the world, especially since nanotechnology has been used to create particles in the nanometer range. Because of their larger specific surface area and improved particle surface reactivity as a result of their smaller particle size, ZnO-NPs have appealing antibacterial qualities. ZnO is a bio-safe substance that affects chemical and biological species through photo-oxidizing and photocatalysis. The Aim of study is to evaluate the antibacterial activity and antibiofilm of Zinc Oxide Nanoparticles (ZnO NPs) against many bacteria isolated from burn infection include P. aeruginosa and S. aureus and Klebsiella. The tests in this study focusing on antibacterial and antibiofilm activity of zinc oxide nanoparticles. The results showed a moderate antibacterial activity by nano zinc oxide where 40% of P. aeruginosa isolates as inhibited, Klebsiella was unaffected, and S. aureus was inhibited. On the other hand, it was exhibit a good antibiofilm activity produced by Pseudomonas aeruginosa and Klebsiella, so the nano zinc oxide shows promise as a potent antibiofilm agent

Recommended Citation

AL-Anssari, Mohammed Jaafar; AL-Hamami, Mohammed Sahib; AL-Ameedee, Hayder Razzaq; Kasema, Rabab Abdul Razzaq; and Mahdi, Hawraa Majid (2026) "Nano zinc oxide against bacteria isolated from burn infection," Al-Bahir: Vol. 8: Iss. 2, Article 7.
Available at: https://doi.org/10.55810/2313-0083.1129

References

[1] Sami Awayid H, Qassim Mohammad S. Prevalence and antibiotic resistance pattern of methicillin-resistant Staphylococcus aureus isolated from Iraqi hospitals. Arch Razi Inst 2022;77(3):1147—56.

[2] Alkhulaifi ZMM, Mohammed KAS. Prevalence and molecular analysis of antibiotic resistance of Pseudomonas aeruginosa isolated from clinical and environmental specimens in Basra, Iraq. Iran J Microbiol 2023;15(1):45.

[3] Sirelkhatim A, Mahmud S, Seeni A, Kaus NHM, Ann LC, Bakhori SKM, et al. Review on zinc oxide nanoparticles: antibacterial activity and toxicity mechanism. Nano-Micro Lett 2015;7:219—42.

[4] Frieri M, Kumar K, Boutin A. Antibiotic resistance. J Infect Public Health 2017;10(4):369—78.

[5] Abbasi R, Shineh G, Mobaraki M, Doughty S, Tayebi L. Structural parameters of nanoparticles affecting their toxicity for biomedical applications: a review. J Nanoparticle Res 2023;25(3):43.

[6] Hasan A, Waibhaw G, Saxena V, Pandey LM. Nano-biocomposite scaffolds of chitosan, carboxymethyl cellulose and silver nanoparticle modified cellulose nanowhiskers for bone tissue engineering applications. Int J Biol Macromol 2018;111:923—34.

[7] Johnston HJ, Hutchison G, Christensen FM, Peters S, Hankin S, Stone V. A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol 2010;40(4):328—46.

[8] Wang H, Zhang W, Ladika D, Yu H, Gailevicius D, Wang H, et al. Two-photon polymerization lithography for optics and photonics: fundamentals, materials, technologies, and applications. Adv Funct Mater 2023;33(39):2214211.

[9] Karnwal A, Kumar Sachan RS, Devgon I, Devgon J, Pant G, Panchpuri M, et al. Gold nanoparticles in nanobiotechnology: from synthesis to biosensing applications. ACS Omega 2024;9(28):29966—82.

[10] Hadi N, Dawood H. Antibacterial activity of modified zinc oxide nanoparticles against Pseudomonas aeruginosa isolates of burn infections. World Sci News 2016;33:1.

[11] Sangani MH, Moghaddam MN, Mahdi M. Inhibitory effect of zinc oxide nanoparticles on Pseudomonas aeruginosa biofilm formation. Nanomed J 2015;2(2):121—8.

[12] Zhong L, Liu H, Samal M, Yun K. Synthesis of ZnO nanoparticles-decorated spindle-shaped graphene oxide for application in synergistic antibacterial activity. J Photochem Photobiol B Biol 2018;183:293—301.

[13] Sies H, Jones DP. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat Rev Mol Cell Biol 2020;21(7):363—83.

[14] Dwyer DJ, Collins JJ, Walker GC. Unraveling the physiological complexities of antibiotic lethality. Annu Rev Pharmacol Toxicol 2015;55(1):313—32.

[15] Primozic M, Knez Z,  Leitgeb M. (Bio) Nanotechnology in food science―food packaging. Nanomaterials 2021;11(2): 292.

[16] Pang Z, Raudonis R, Glick BR, Lin T-J, Cheng Z. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnol Adv 2019;37(1): 177—92.

[17] Nakae T. Role of membrane permeability in determining antibiotic resistance in Pseudomonas aeruginosa. Microbiol Immunol 1995;39(4):221—9.

[18] Poole K. Pseudomonas aeruginosa: resistance to the max. Front Microbiol 2011;2:65. [19] Pang Z, Raudonis R, Glick BR, Lin TJ, Cheng Z. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnol Adv 2019 Jan 1;37(1):177—92.

[20] Bodey GP, Bolivar R, Fainstein V, Jadeja L. Infections caused by Pseudomonas aeruginosa. Rev Infect Dis 1983;5(2):279—313.

[21] Mohanty S, Baliyarsingh B, Nayak SK. Antimicrobial resistance in Pseudomonas aeruginosa: a concise review. In: Mares¸ M, Lim SHE, Lai K-S, Cristina R-T, editors. Antimicrobial resistance - a one health perspective [Internet]. London: IntechOpen; 2020. https://doi.org/10.5772/intechopen.88706. Available from:.

[22] Pseudomonas aeruginosa infection [Internet]. Cleveland Clinic 2023. Available from: https://my.clevelandclinic.org/health/ diseases/25164-pseudomonas-infection.

[23] Applerot G, Lipovsky A, Dror R, Perkas N, Nitzan Y, Lubart R, et al. Enhanced antibacterial activity of nanocrystalline ZnO due to increased ROS-mediated cell injury. Adv Funct Mater 2009;19(6):842—52.

[24] Khan I, Saeed K, Khan I. Nanoparticles: properties, applications and toxicities. Arab J Chem 2019;12(7):908—31.

[25] Jalal R, Goharshadi EK, Abareshi M, Moosavi M, Yousefi A, Nancarrow P. ZnO nanofluids: green synthesis, characterization, and antibacterial activity. Mater Chem Phys 2010; 121(1—2):198—201. 206 AL-BAHIR (JOURNAL FOR ENGINEERING AND PURE SCIENCES) 2026;8:202—207

[26] Sawai J, Shoji S, Igarashi H, Hashimoto A, Kokugan T, Shimizu M, et al. Hydrogen peroxide as an antibacterial factor in zinc oxide powder slurry. J Ferment Bioeng 1998; 86(5):521—2.

[27] Lipovsky A, Nitzan Y, Gedanken A, Lubart R. Antifungal activity of ZnO nanoparticles―the role of ROS mediated cell injury. Nanotechnology 2011;22(10):105101.

[28] Zhang L, Ding Y, Povey M, York D. ZnO nanofluids–A potential antibacterial agent. Prog Nat Sci 2008;18(8):939—44.

[29] Kasemets K, Ivask A, Dubourguier H-C, Kahru A. Toxicity of nanoparticles of ZnO, CuO and TiO2 to yeast Saccharomyces cerevisiae. Toxicol Vitro 2009;23(6):1116—22.

[30] Brunner TJ, Wick P, Manser P, Spohn P, Grass RN, Limbach LK, et al. In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. Environ Sci ∖& Technol 2006;40(14): 4374—81. [31] Li M, Zhu L, Lin D. Toxicity of ZnO nanoparticles to Escherichia coli: mechanism and the influence of medium components. Environ Sci ∖& Technol 2011;45(5):1977—83.

[32] Brayner R, Ferrari-Iliou R, Brivois N, Djediat S, Benedetti MF, Fievet  F. Toxicological impact studies based on Escherichia coli bacteria in ultrafine ZnO nanoparticles colloidal medium. Nano Lett 2006;6(4):866—70.

[33] Zhang L, Jiang Y, Ding Y, Povey M, York D. Investigation into the antibacterial behaviour of suspensions of ZnO nanoparticles (ZnO nanofluids). J Nanoparticle Res 2007;9: 479—89.

[34] Adams LK, Lyon DY, Alvarez PJJ. Comparative eco-toxicity of nanoscale TiO2, SiO2, and ZnO water suspensions. Water Res 2006;40(19):3527—32.

[35] Holt JG, Krieg NR, Sneath PHA, Staley JT, Williams ST. Bergey's manual of determinative bacteriology. 1994. p. 786—8. 9th. Balt William∖& Wilkins.

[36] Aldujaili NH, Alzubaidy FH, Hussein AA. Extracellular synthesis of silver nanoparticles by Acinetobacter baumanii and antibacterial characterization. Ann Trop Med Public Heal 2020;23(18).

[37] Hussein AA, Aldujaili NH. Antimicrobial, antibiofilm, and antioxidant activity of chitosan nanoparticles synthesized by E. coli. Journal of Physics: Conference Series 2020:12118.

[38] Rajabi H, Salimizand H, Khodabandehloo M, Fayyazi A, Ramazanzadeh R. Prevalence of algD, pslD, pelF, Ppgl, and PAPI-1 genes involved in biofilm formation in clinical Pseudomonas aeruginosa strains. Biomed Res Int [Internet] 2022;(1): 1716087. https://doi.org/10.1155/2022/1716087. Available from:.

[39] Bamneshin K, Poudineh M, Alibabaei RH, Amiri MRJ, Fateminasab ZS, Ghorbani Z, et al. Prevalence of icaADBC genes, and correlation with biofilms and antibiotic resistance in S. aureus: a systematic review and meta-analysis. Germs 2024;14(4):387. [40] Sahoo K, Meshram S, Sahoo Jr K. Biofilm formation in chronic infections: a comprehensive review of pathogenesis, clinical implications, and novel therapeutic approaches. Cureus 2024;16(10).

[41] Li Y, Liao C, Tjong SC. Recent advances in zinc oxide nanostructures with antimicrobial activities. Int J Mol Sci [Internet] 2020 Nov 22;21(22):8836. Available from: https:// www.mdpi.com/1422-0067/21/22/8836.

[42] Rasmussen JW, Martinez E, Louka P, Wingett DG. Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications. Expert Opin Drug Deliv 2010;7(9):1063—77.

[43] Padmavathy N, Vijayaraghavan R. Enhanced bioactivity of ZnO nanoparticles―an antimicrobial study. Sci Technol Adv Mater 2008;9(3):035004.

[44] Jiang S, Lin K, Cai M. ZnO nanomaterials: current advancements in antibacterial mechanisms and applications. Front Chem 2020;8:580.

[45] Udayagiri H, Sana SS, Dogiparthi LK, Vadde R, Varma RS, Koduru JR, et al. Phytochemical fabrication of ZnO nanoparticles and their antibacterial and anti-biofilm activity. Sci Rep 2024;14(1):19714.

[46] Valadbeigi H, Sadeghifard N, Kaviar VH, Haddadi MH, Ghafourian S, Maleki A. Effect of ZnO nanoparticles on biofilm formation and gene expression of the toxin-antitoxin system in clinical isolates of Pseudomonas aeruginosa. Ann Clin Microbiol Antimicrob 2023;22(1):89.

[47] Ibrahem EJ, Yasin YS, Jasim OK. Antibacterial activity of zinc oxide nanoparticles against Staphylococcus aureus and Pseudomonas aeruginosa isolated from burn wound infections. Cihan Univ Sci J 2017;10:24086.

[48] Wahab R, Kim Y-S, Mishra A, Yun S-I, Shin H-S. Formation of ZnO micro-flowers prepared via solution process and their antibacterial activity. Nanoscale Res Lett 2010;5: 1675—81.

[49] Hemdan BA, El-Naggar ME, Abd-Elgawad SE, El Zawawy NA, Mahmoud YA-G. Bacterial cell-free metabolites-based zinc oxide nanoparticles for combating skincausing bacterial infections. Biomass Convers Biorefinery [Internet] 2024;14(19):23381—94. https://doi.org/10.1007/ s13399-023-04313-7. Available from:.

[50] Fan G, Xiao Q, Li Q, Xia Y, Feng H, Ma X, et al. Antimicrobial mechanisms of ZnO nanoparticles to phytopathogen Pseudomonas syringae: damage of cell envelope, suppression of metabolism, biofilm and motility, and stimulation of stomatal immunity on host plant. Pestic Biochem Physiol 2023;194:105455.